Our software solutions

Medis QFR^®

Image-based coronary physiology powered by AI Deep Learning

Simple

Simple intuitive workflow, applicable for online and offline usage.

Fast

No pressure wire, no adenosine, reduces treatment costs and procedure time.

Proven

Best evidence base of any clinical angiography-based FFR Method

What is Medis QFR^® ?

Medis QFR® is an image-based functional assessment of coronary obstructions from standard coronary angiograms. This software solution offers a simple, intuitive workflow, applicable for online and offline usage to fit your clinical needs.

QFR^® Results
3D anatomic info for stent sizing
Allows prioritization of serial lesions
Residual QFR® predicts the effect of an intervention on the resulting QFR® value
User Lesion: Lesions can be combined by adding user lesion, so the lesion can be compared for optimal treatment planning

What is new in the latest version of Medis QFR^®?

Read all about Medis QFR^® in one of our scientific blogs

Hans Reiber, the CSO of Medis Medical Imaging, will discuss the latest publications on Medis QFR^®.

The latest developments of Medis QFR® - June 2023 edition

14-06-2023 – 7 mins

In this Medis QFR^® blog, we are proud to share five publications on the latest developments of Medis QFR with you…

The latest developments of Medis QFR® - March 2023 edition

24-03-2023 – 10 mins

In this Medis QFR^® blog, we are proud to share 7 publications on the latest developments of Medis QFR with you…

The latest developments of Medis QFR® - February 2023 edition

02-02-2023 – 6 mins

In this new Medis QFR^® blog, we are proud to share four publications on the latest developments of Medis QFR with you…

“We have been using QFR^® since 2022. It will streamline the Cath Lab workflow, increasing the pre and post adoption of coronary physiology. For me, the benefits of QFR^® are both the cost effectiveness as well as the time efficiency.”

Dr. Yuhei Kobayashi

This technique is simpler, safer and less expensive with equivalent outcomes and will conceivably be readily and widely adopted. Angiographically derived FFR, and specifically QFR^®, should, in the future, be used routinely, reserving the invasive wire-based FFR approach for the challenging minority of cases where QFR^® accuracy is questioned.

Dr. Morton J. Kern

“State-of-the-art approach in acute coronary syndrome targets on the “pancoronary risk”. This can be assessed easily, safely, and reproducibly by QFR^®.”

Dr. Leistner

“I am a strong believer QFR^® adds invaluable parameters to the diagnostic angiogram. This will move us to one test that will give us all the information.”